investor login
contact
team
dedicated funds
news
portfolio
Developing first-in-class approach to activate myeloid cells to kill cancer.
VISIT
WEBSITE
Active
,
Bio Tech
,
HOF I
,
HVP VI
back to portfolio
contact
team
dedicated funds
news
home
portfolio